Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

WheezoMeter® Correlation Study

This study has been terminated.
(Device revised)
Information provided by (Responsible Party):
iSonea Identifier:
First received: March 15, 2012
Last updated: August 16, 2013
Last verified: August 2013
The primary goal of the study is to more firmly establish correlations between WheezeRate(Wz%) and other parameters used to assess wheezing and asthma including spirometry, provider's auscultation, and symptoms at the time of Wz% measurement.


Study Type: Observational
Study Design: Observational Model: Case Control
Time Perspective: Prospective
Official Title: Prospective Comparative Study of WheezeRATE™ (Wz%) Readings With Spirometry, Symptoms, and Auscultatory Findings in Children With Wheezing.

Further study details as provided by iSonea:

Enrollment: 19
Study Start Date: March 2012
Study Completion Date: March 2013
Primary Completion Date: March 2013 (Final data collection date for primary outcome measure)
Active Wheezing - age 5-12
Active Wheezing - under age 5
No Wheezing


Ages Eligible for Study:   up to 12 Years   (Child)
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population
Pediatric Specialty Clinic

Inclusion Criteria:

  • Patients <= 12 years of age who have wheezing at the time of study as confirmed by the physicians' auscultation.


  • Patients <= 12 years of age without history of asthma or other pulmonary conditions, and who are without wheezing on physical exam.

Exclusion Criteria:

  • Medical problems that would contraindicate Wz% measurement.
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT01556958

United States, California
Site 1
Folsom, California, United States, 95630
Sponsors and Collaborators
  More Information

Responsible Party: iSonea Identifier: NCT01556958     History of Changes
Other Study ID Numbers: iS-2012-Wz 
Study First Received: March 15, 2012
Last Updated: August 16, 2013
Health Authority: United States: Institutional Review Board

Additional relevant MeSH terms:
Bronchial Diseases
Respiratory Tract Diseases
Lung Diseases, Obstructive
Lung Diseases
Respiratory Tract Infections processed this record on October 25, 2016